Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.
about
HMGB1: endogenous danger signalingDual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studiesPostulates for validating TLR4 agonistsDamage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.Toll-like receptors in pathophysiology of liver diseasesObesity: An Immunometabolic PerspectiveProtein kinase C-zeta (PKC-zeta) regulates Kupffer cell apoptosis during experimental sepsisInhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in ratsDesflurane preconditioning induces oscillation of NF-κB in human umbilical vein endothelial cellsThe identity of innate immune activators in organ transplantation: origins from within or exterior to the host?Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2.CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension.The innate immune system in allograft rejection and tolerance.Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways.Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study.TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.Microbiota-liver axis in hepatic disease.Contribution of gut bacteria to liver pathobiology.Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion.Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.The microbiota regulates susceptibility to Fas-mediated acute hepatic injuryCancer and inflammation: promise for biologic therapy.Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy.T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent mannerToll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.Toll-like receptor 4 implicated in acute lung injury induced by paraquat poisoning in mice.Minocycline protects against hepatic ischemia/reperfusion injury in a rat model.Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice.Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6.CXC chemokine signaling in the liver: impact on repair and regeneration.Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells.T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice.
P2860
Q24645232-86792A8F-2143-4993-9501-B7802581FCB4Q26825632-3768773D-02B1-41DE-A9E1-BF6E4E4B3D8CQ27023992-F0C95FF9-DA45-43A4-AF7D-E5C2D541DDFFQ27334890-940081A8-3BD1-40F3-B2C6-DAB9C0C1EC4CQ28070077-FA6FBD27-2348-420E-80A9-113E5243C5E9Q28072140-EB9E446B-ED5B-445D-8990-C5F0FAAD2B65Q28584030-60EA2E30-25DE-42CE-9BF2-9645D22814D3Q28728804-73FA8E45-CAD2-4DAD-8D23-FEE8A005B8ADQ31121128-ADF93ABE-00A9-4C8C-AF70-88F4A357A349Q33285697-1EFB83C1-BF82-4C60-A73E-C64A90233463Q33579223-2FC8504E-F520-496A-AE15-901451D3CB05Q33585866-C6B7FB7B-BF42-445E-8E1F-0AB944667B19Q33698036-A8F586B5-94CE-4298-A06B-74257058D079Q33732470-28E8D48F-223D-4E20-AA32-FFAA7B582437Q33747476-B5DAAEA2-220A-4982-A713-00A18F354AB6Q33751850-373542A3-40B0-4F93-92E3-52E7F8B9A7E6Q33769592-A69EEE7A-0C93-46DF-AEAE-E532EB13D4F2Q33845593-98C313B0-517A-4581-9852-8D5159BC4D7CQ33855414-40AF72E8-CBA8-4804-B6E2-D054751C5894Q34035372-C8742110-ABC9-46C6-B064-24312BAAA76EQ34035581-860FC3A9-9525-4AEF-B9A6-9D0E4775F278Q34110431-0BF2216F-982D-4DD9-86ED-08136CAF5D1BQ34121869-2C44098D-98B7-49E8-A0E5-76826C17B27DQ34122986-AAA48884-AA3C-4B6B-9F27-10DCF01FFF4AQ34139732-4A38BE38-C949-4A2F-828D-3CC1F7A1CB79Q34145920-4D01965E-3D89-45F5-B009-EA53BEEB463EQ34268218-000A7E76-6663-4F62-8DCF-1C6C07461C27Q34321742-EC68C0CA-8443-40A5-98A0-1C34D5E6B6E9Q34547690-304BFFD7-2343-4512-BF87-AD9D8F884C47Q34607340-CD716FB7-8CD4-427F-9F4E-FC5AB4661184Q34753189-566F97B0-22DB-46E9-9C1E-D285CD68BE86Q34979277-907BB887-3A34-4CD6-966F-1FB80A86A64CQ35023053-2A711482-0708-4900-A4B1-0B11C7BBF3BDQ35131974-4D3B50D2-971E-4C2E-A9C5-A225679F9290Q35192812-04923951-6A7F-4B9D-BEA6-3ABAFD1ED3E4Q35200037-E85D1EC4-A8B4-454B-BC95-02A6309FA1D6Q35219027-02E76996-12ED-4271-B9A5-B5FA192A2A90Q35402021-6EB1C694-1F47-4EF7-9FF2-CB683D545414Q35415661-32E8F392-A153-4128-9F64-9999B662BAF9Q35541859-D166283E-28A3-4BBF-9BB4-7C09BD19BAE9
P2860
Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@en
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@nl
type
label
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@en
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@nl
prefLabel
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@en
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@nl
P2093
P1476
Hepatic ischemia/reperfusion i ...... aling in nonparenchymal cells.
@en
P2093
Allan Tsung
Atsunori Nakao
David A Geller
Kunihiko Izuishi
Meagan H Chan
Michael T Lotze
Nathan D Critchlow
Rosemary A Hoffman
Timothy R Billiar
P304
P356
10.4049/JIMMUNOL.175.11.7661
P407
P577
2005-12-01T00:00:00Z